Vitamin K2 and Cancer

Vitamin K is a fat-soluble vitamin best known for its role in blood clotting and bone health. It includes several forms, including vitamin K1 and vitamin K2. Vitamin K1 is found mainly in green leafy vegetables, while vitamin K2 refers to a group of menaquinones found in certain animal-based and fermented foods. The NIH notes that vitamin K supports blood clotting proteins and bone-related proteins, and that people taking warfarin or similar anticoagulants need consistent vitamin K intake.

In recent years, vitamin K2 has also been studied for possible roles in cancer-related pathways. This research is scientifically interesting, but vitamin K2 is not a cancer treatment and should not be used in place of oncology care.

What Is Vitamin K2?

Vitamin K2 is part of the vitamin K family. It is involved in several biological processes, including activation of vitamin K-dependent proteins.

Vitamin K is often discussed for:

• Blood clotting
• Bone metabolism
• Vascular health research
• Cellular signaling
• Nutritional wellness

Because vitamin K is fat-soluble, it is absorbed better when taken with dietary fat.

Vitamin K2 and Cancer Research

Some laboratory studies have explored vitamin K2’s potential effects on cancer-related processes, including cell growth, programmed cell death, invasion behavior, and interactions with certain cancer therapies.

These findings are early-stage and should be interpreted carefully. Results from cell studies or small clinical trials do not mean vitamin K2 has been proven to prevent or treat cancer in patients.

Vitamin K2 and Liver Cancer Research

One phase II randomized study evaluated sorafenib with or without vitamin K treatment in patients with hepatocellular carcinoma. The study reported improved response rate, progression-free survival, and overall survival in the combination group.

While these findings are notable, they do not establish vitamin K2 as a standard cancer treatment. More research is needed to understand which patients may benefit, what dosing is appropriate, and how vitamin K2 may interact with cancer therapies.

Safety and Medication Considerations

Vitamin K can interact with certain anticoagulant medications, especially warfarin. Patients taking blood thinners should not start, stop, or change vitamin K intake without medical guidance.

Speak with a healthcare professional before taking vitamin K2 if you:

• Take warfarin or another anticoagulant
• Are undergoing cancer treatment
• Have liver disease
• Take chemotherapy, targeted therapy, or immunotherapy
• Are pregnant or nursing
• Have a bleeding or clotting disorder
• Take multiple supplements or medications

Food Sources of Vitamin K

Vitamin K1 is found mainly in leafy greens, while vitamin K2 is found in certain fermented and animal-based foods.

Food sources may include:

• Kale
• Spinach
• Broccoli
• Collard greens
• Natto
• Certain cheeses
• Eggs
• Some meats
• Fermented foods

For most people, a balanced diet can help support vitamin K intake.

Talk to Your Oncology Team First

Patients interested in vitamin K2 during cancer treatment should speak directly with their oncologist or qualified healthcare provider. Even natural supplements can affect treatment plans, lab values, bleeding risk, or medication response.

A pharmacist can also help review medication and supplement interactions as part of a provider-guided care plan.

Final Takeaway

Vitamin K2 is an important nutrient with established roles in normal body function and ongoing research interest in cancer-related pathways. However, it is not approved as a cancer treatment and should never replace medical care.

The safest approach is to discuss vitamin K2 with your healthcare provider, especially if you are being treated for cancer or take blood-thinning medication.